Most of the money would be distributed to states in less than a year and be used to combat the opioid overdose epidemic
THURSDAY, Feb. 4, 2021 (HealthDay News) — A deal has been reached for business consulting firm McKinsey & Company to pay $573 million to settle U.S. lawsuits over its role in the nation’s opioid crisis, according to a person with knowledge of the agreement.
The global company faced legal action from the District of Columbia and dozens of states and territories for advising companies on how to “supercharge” sales of prescription opioids, the Associated Press reported.
Most of the money in the national settlement would be distributed to states in less than a year and be used to combat the opioid overdose epidemic. Announcements about the settlement are expected Thursday.
For the past few years, state and local governments have been filing lawsuits against companies that make and sell prescription opioids for their role in the opioid crisis, but going after a consulting firm is a new tactic, the AP reported.
As of Wednesday night, the company had not responded to calls or emails from the news service.
Distinct Characteristics ID"d for Patients With Rheumatoid Conditions, Opioid Use Disorder 
People Using Illicitly Sourced Fentanyl Face Worse Outcomes Than Medically Sourced Users 
CDC: Buprenorphine Treatment Differs in Urban, Rural Areas .jpeg)
Breathing Interventions May Curb Cravings With Substance Use 
Air Pollution Tied to Higher Risk for Suicide 
Psychiatrists Only Agree 55 Percent of the Time on Diagnoses 
2021 to 2026 Saw Increase in State Funding for Suicide Prevention 
Screening + Online Cognitive Behavioral Therapy Program Aids Nurses" Mental Health 
